SXG Pharmaceutical was founded in 1909, the first year of the Reign of Emperor Xuantong in the Qing Dynasty, and is located in the Yangtze River basin of China at 30N - Wuyi, Zhejiang,China. This city was awarded as one of the three "Global Green Cities" by GFHS-XII in 2017. This place has a mild and humid climate, abundant rainfall and abundant vegetation, which is a paradise for the growth of many traditional Chinese herbal medicines. SXG has built approx. 338 hectares standardized organic cultivation bases imitating wild growth conditions for Ganoderma, Dendrobium, Crocus and many herbal medicines, and achieved organic certification from China, US, EU, and Japan, China's GAP certification and Authentic medicinal material certification.As a leading manufacturer of high-quality herbal medicine supplements in China, SXG has constructed the whole industry chain of traditional Chinese medicine (TCM) including breeding, cultivation, manufacturing, development and marketing,and built GMP factory of more than 11,000 square meters for product production. The company always adheres to the "Develop natural organic products to serve for people's health, beauty and longevity." as its principle, and advocates the concept of health and wellness about "the harmony of heaven, human and earth", and dedicates to redefining traditional oriental herbal medicine by integrating the advantages of advanced science, and provides health solutions to enhance the overall power of natural herbal medicine. Over the past 100 years, SXG is well recognized by customers due to its high product quality and excellent service, and has become the first stock in the Chinese Ganoderma and Dendrobium industries(Stock code:603896).SXG has a strong scientific research team consisting of experts and scholars in the fields of medicine, pharmacy, and nutriology. The research center covers an area of more than 12,000 square meters, and is equipped with 15 technical function labs, including the Molecular Biology Lab, Breeding Lab, Mass spectrometry Lab and Chromatography Lab, etc. Till now, 10 new cultivars of Ganoderma, Dendrobium and medicinal and edible mushrooms have been bred and certified.SXG attaches great attention to scientific research, standardization and international cooperation. The annual R&D spending is higher than 6%, and a number of pharmacological, preclinical and clinical studies have been conducted, which ensure the quality and efficacy of the products. SXG has developed a unique and patented sporoderm-removal technique for Ganoderma spore production, which removes the spore wall thereby greatly improving the contents of active constituents and product efficacy.SXG has developed 92 TCM standards including ISO standards of Ganoderma(ISO 21315) and Dendrobium(ISO 21370). SXG has also cooperated with global research institutions such as Mayo Clinic, Wayne State University,European Precision Medicine Platform, Peking University, Zhejiang University, etc, in the research of TCM prevention and treatment of tumor, immunoregulation, cardiovascular dysfunction, and aging. In 2018, SXG "Sporoderm-removal Ganoderma lucidum Spore Powder" won the gold medal in the 46th International Invention Exhibition in Geneva. At the 57th World Congress of Traditional Chinese Medicine,"SXG Sporoderm-removal Ganoderma lucidum Spore Powder" and "SXG Dendrobium and Ganoderma Extract" won the "International Health Star of Traditional Chinese Medicine in the 21st Century" award.
